IP Library Granted Patent US 10,010,496
Granted Patent B2
US 10,010,496 · App. 15/664,542 · Granted Jul 3, 2018

Topical sanitizing formulations and uses thereof

Inventors: Jesse Cozean (Lake Forest, CA); Colette Cozean (Lake Forest, CA); Susan Goldsberry (Huntington Beach, CA)
Assignee: Innovative BioDefense, Inc.
A61K8/498A61K8/31A61K8/34A61K8/416A61K8/43A61K8/678A61K31/045A61K31/14A61K31/155A61K31/355A61K31/717A61K31/785A61K33/30A61K36/61A61K45/06A61Q17/005A61Q19/007A61Q19/10A61K2800/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,496
App. No.
15/664,542
Granted
Jul 3, 2018
Kind
B2
Abstract

Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.

Claims (42)

1. A sanitizing formulation comprising, by weight:

about 20% to about 30% water;

about 0.2% to about 2.0% panthenol;

about 60% to about 75% ethyl alcohol;

about 0.05% to about 0.5% PEG-12 dimethicone;

about 0.1% to about 2.0% farnesol;

about 0.05% to about 1.0% benzethonium chloride; and

about 0.5% to about 4.0% polyaminopropyl biguanide.

2. The formulation of claim 1 , wherein the panthenol comprises a racemic mixture of D- and L-panthenol.

3. The formulation of claim 2 , wherein the formulation comprises about 1.0% panthenol.

4. The formulation of claim 1 , wherein the formulation comprises about 69% ethyl alcohol.

5. The formulation of claim 1 , wherein the formulation comprises about 0.1% to about 0.3% PEG-12 dimethicone.

6. The formulation of claim 5 , wherein the formulation comprises about 0.2% PEG-12 dimethicone.

7. The formulation of claim 1 , wherein the formulation comprises about 0.1% to about 1.0% farnesol.

8. The formulation of claim 1 , wherein the formulation comprises about 0.5% farnesol.

9. The formulation of claim 1 , wherein the formulation comprises about 0.05% to about 0.2% benzethonium chloride.

10. The formulation of claim 9 , wherein the formulation comprises about 0.12% benzethonium chloride.

11. The formulation of claim 1 , wherein the formulation comprises about 0.5% to about 3.0% polyaminopropyl biguanide.

12. The formulation of claim 11 , wherein the formulation comprises about 1.5% polyaminopropyl biguanide.

13. The formulation of claim 1 , further comprising about 0.4% to about 1.0% hydroxyethyl ethylcellulose.

14. The formulation of claim 13 , wherein the formulation comprises about 0.7% hydroxyethyl ethylcellulose.

15. The formulation of claim 1 , wherein the formulation is a sanitizing gel formulation.

16. The formulation of claim 1 , wherein the formulation is a sanitizing non-gel formulation.

17. The formulation of claim 1 , wherein the formulation is a surgical scrub.

18. A method of microbial reduction, comprising applying a formulation of claim 1 to a surface in need thereof.

19. A sanitizing formulation comprising, by weight:

about 20% to about 30% water;

about 1.0% D,L-panthenol;

about 0.7% hydroxyethyl ethylcellulose;

about 60% to about 75% ethyl alcohol;

about 0.2% PEG-12 dimethicone;

about 0.5% farnesol;

about 0.12% benzethonium chloride; and

about 1.5% polyaminopropyl biguanide.

20. A sanitizing formulation comprising, by weight:

about 20% to about 30% water;

about 1.0% D,L-panthenol;

about 60% to about 75% ethyl alcohol;

about 0.2% PEG-12 dimethicone;

about 0.5% farnesol;

about 0.12% benzethonium chloride; and

about 1.5% polyaminopropyl biguanide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2018
From: COZEAN, JESSE; COZEAN, COLETTE; GOLDSBERRY, SUSAN
To: INNOVATIVE BIODEFENSE, INC.
Reel/Frame 046873/0064 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2018
From: COZEAN, JESSE; COZEAN, COLETTE; GOLDSBERRY, SUSAN
To: INNOVATIVE BIODEFENSE, INC.
Reel/Frame 046038/0789 →
SECURITY INTEREST Recorded Mar 22, 2018
From: INNOVATIVE BIODEFENSE INC
To: DAY FAMILY TRUST, PRO RATA; LEWIS, PRO RATA, BARRY; COZEAN FAMILY TRUST, PRO RATA; INTERNATONAL SPECIALTY CHEMICALS AND PHARMACEUTICALS INC, PRO RATA
Reel/Frame 045668/0434 →
Continuity (3)
Continuation 14416010
Provisional Application 61674779 · Jul 23, 2012
Related Publication 20170326057A1 · Nov 16, 2017
Cited By (1)
US 12,295,432